Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RISPERIDONE Cause Product substitution issue? 121 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 121 reports of Product substitution issue have been filed in association with RISPERIDONE (Risperidone). This represents 0.2% of all adverse event reports for RISPERIDONE.

121
Reports of Product substitution issue with RISPERIDONE
0.2%
of all RISPERIDONE reports
0
Deaths
16
Hospitalizations

How Dangerous Is Product substitution issue From RISPERIDONE?

Of the 121 reports, 16 (13.2%) required hospitalization, and 4 (3.3%) were considered life-threatening.

Is Product substitution issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RISPERIDONE. However, 121 reports have been filed with the FAERS database.

What Other Side Effects Does RISPERIDONE Cause?

Gynaecomastia (24,453) Off label use (10,376) Abnormal weight gain (9,418) Weight increased (6,885) Emotional disorder (5,809) Product use in unapproved indication (5,551) Drug ineffective (5,232) Injury (4,447) Hyperprolactinaemia (4,124) Galactorrhoea (3,513)

What Other Drugs Cause Product substitution issue?

AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (2,832) BUPROPION (1,578) METHYLPHENIDATE (1,408) CLONAZEPAM (1,288) LAMOTRIGINE (979) ALBUTEROL (864) LEVOTHYROXINE (803) DULOXETINE (766) ESTRADIOL (692) SERTRALINE (636)

Which RISPERIDONE Alternatives Have Lower Product substitution issue Risk?

RISPERIDONE vs RITALIN RISPERIDONE vs RITLECITINIB RISPERIDONE vs RITODRINE RISPERIDONE vs RITONAVIR RISPERIDONE vs RITUXAN

Related Pages

RISPERIDONE Full Profile All Product substitution issue Reports All Drugs Causing Product substitution issue RISPERIDONE Demographics